Overview
From a portfolio lens, BUIDL ($2.70B) and Injective ($490.41M) offer different beta to bitcoin cycles. The overview below keeps the facts first and the narrative second.
Quick winners
Full comparison
| Metric | BUIDL | INJ |
|---|---|---|
| Price | $1,871.67 | $5.05 |
| Market Cap | $2.70B | $490.41M |
| FDV | — | — |
| Volume 24h | $0.000000 | $2.66M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 35.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.50% | +5.78% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | BUIDL | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.00% | +3.10% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | BUIDL | INJ |
|---|---|---|
| RSI | 54.31 | 53.92 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 66.45 | 0.29 |
| ADX | 20.44 | 12.69 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (56.70 vs 48.70) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | BUIDL | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
BUIDL
Injective
Pros and cons
Pros of BUIDL
- Higher ranking for BUIDL can translate into tighter spreads on major venues.
- Market-cap scale on BUIDL may dampen some idiosyncratic shocks versus smaller peers.
Cons of BUIDL
- Large-cap status for BUIDL can mean slower percentage upside versus high-beta alternatives.
- When dominance narratives fade, BUIDL can lag hotter rotation names.
- Indicator stacks on BUIDL may stay stretched longer than expected in strong trends.
- Regulatory or macro headlines can hit BUIDL harder simply because it is more visible.
Pros of Injective
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- If technical momentum aligns, Injective may outperform on medium-term windows.
Cons of Injective
- Trend failures on Injective often travel faster than on more established assets.
- Relative underperformance versus BUIDL can persist through entire market regimes.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
Which looks stronger right now?
If you weight capitalization and liquidity, BUIDL looks sturdier; if you weight 24h tape, Injective is ahead. A balanced view treats both as incomplete signals.
AI summary
This AI-assisted summary starts from live PEPS fields. BUIDL holds market-cap $2.70B and rank #35; Injective shows $490.41M and #99. Where liquidity and flow matter, watch Injective. Where durability matters, watch BUIDL. AI composite scores (56.70/48.70) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, BUIDL or Injective?
“Better” depends on horizon and risk. BUIDL leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, BUIDL or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both BUIDL and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.